Zdrowie i gospodarka · 16/03/2022
FDA Releases Draft Guidance for Human Gene Therapy Products Involving Genome Editing
The FDA has made available a draft document outlining recommendations for sponsors developing human gene therapy products that incorporate genome editing, focusing on information required for IND applications to assess product safety and quality.
Source: Federal Register — Food and Drug AdministrationOpen original release →